2021-01-11,INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium
2021-01-06,Biotech Stock Roundup: MRNA's COVID-19 Vaccine Updates & Other Pipeline Updates
2021-01-05,Calithera (CALA) Plunges as CANTANA Study on Telaglenastat Fails
2021-01-05,Calithera to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
2021-01-04,Why Calithera Biosciences Stock Is Plunging Today
2021-01-04,Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint
2020-12-31,Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-12-28,Our Take On Calithera Biosciences' (NASDAQ:CALA) CEO Salary
2020-12-14,Is CALA A Good Stock To Buy Now?
2020-12-11,Do Options Traders Know Something About Calithera (CALA) Stock We Don't?
2020-12-02,Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-11,Calithera to Participate in Jefferies Virtual Healthcare Conference and SVB Leerink Oncology 1x1 Day
2020-11-09,Calithera Biosciences Presents New Preclinical Data for CB-668 at Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting
2020-11-06,Calithera Biosciences Inc (CALA) Q3 2020 Earnings Call Transcript
2020-11-05,Calithera Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights
2020-11-05,"Calithera Biosciences, Inc. to Host Earnings Call"
2020-11-04,Calithera Biosciences Announces Expansion of Ongoing Clinical Trial Evaluating Telaglenastat in Combination with palbociclib (IBRANCEÂ®)
2020-11-02,Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-02,"Calithera Biosciences Awarded up to $2.4M from Cystic Fibrosis Foundation to Support Clinical Development of Arginase Inhibitor, CB-280"
2020-10-30,"What Is The Ownership Structure Like For Calithera Biosciences, Inc. (NASDAQ:CALA)?"
2020-10-29,"Calithera Biosciences to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020"
2020-10-07,Calithera Biosciences CB-280 Arginase Inhibitor Trial in Progress Poster Presented at the North American Cystic Fibrosis 2020 Virtual Conference
2020-10-02,Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-09-24,Calithera Biosciences Initiates KEAPSAKE Randomized Phase 2 Trial of Telaglenastat in Combination with Chemoimmunotherapy to Treat Aggressive Form of Lung Cancer
2020-09-11,2 Strong Buy Healthcare Stocks Under $5 With Massive Upside Potential
2020-09-04,Calithera to Participate in Multiple Upcoming Investor Conferences
2020-09-02,Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-08-18,Companies Like Calithera Biosciences (NASDAQ:CALA) Are In A Position To Invest In Growth
2020-08-11,Calithera Biosciences Inc (CALA) Q2 2020 Earnings Call Transcript
2020-08-10,Calithera Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
2020-08-03,Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-07-28,"Calithera Biosciences to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020"
2020-07-14,Calithera Biosciences Appoints Scott Garland to Board of Directors
2020-07-13,Calithera Biosciences Initiates Phase 1b Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis
2020-07-06,Hedge Funds Are Selling Calithera Biosciences Inc (CALA)
2020-07-02,Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-06-02,Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-05-29,Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at ASCO20 Virtual Annual Meeting
2020-05-27,Calithera to Present at the Jefferies Virtual Healthcare Conference
2020-05-26,Edited Transcript of CALA earnings conference call or presentation 7-May-20 9:00pm GMT
2020-05-18,Has Calithera Biosciences (CALA) Outpaced Other Medical Stocks This Year?
2020-05-13,Is Calithera Biosciences (CALA) Stock a Solid Choice Right Now?
2020-05-11,What Makes Calithera (CALA) a New Buy Stock
2020-05-08,Calithera Biosciences Inc (CALA) Q1 2020 Earnings Call Transcript
2020-05-07,Calithera Biosciences Reports First Quarter 2020 Financial Results and Recent Highlights
2020-05-06,Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-05-01,"Calithera Biosciences to Report First Quarter 2020 Financial Results on Thursday, May 7, 2020"
2020-04-30,Calithera Biosciences Announces Telaglenastat KEAPSAKE Trial in Progress Abstract Accepted for Presentation at ASCO20 Virtual Annual Meeting
2020-04-20,"Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares"
2020-04-16,"Calithera Biosciences, Inc. Prices Public Offering of 5,000,000 shares of Common Stock"
2020-04-15,"Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock"
2020-04-14,Calithera (CALA) Soars: Stock Adds 9.4% in Session
2020-04-14,Calithera Biosciences Provides Update on Business Operations
2020-04-13,How to Play Speculative Calithera Biosciences
2020-04-07,Billionaire Steven Cohen Picks up These 2 Stocks on the Dip
2020-03-30,Edited Transcript of CALA earnings conference call or presentation 11-Mar-20 9:00pm GMT
2020-03-28,"Have Insiders Been Buying Calithera Biosciences, Inc. (NASDAQ:CALA) Shares?"
2020-03-11,Calithera Biosciences Reports Fourth Quarter 2019 Financial Results and Recent Highlights
2020-03-11,"Calithera Biosciences, Inc. to Host Earnings Call"
2020-03-04,"Calithera Biosciences to Report Fourth Quarter 2019 Financial Results on Wednesday, March 11, 2020"
2020-02-19,Calithera to Participate in the 9th Annual SVB Leerink Global Healthcare Conference
2020-01-30,"Is Calithera Biosciences, Inc.'s (NASDAQ:CALA) CEO Paid Enough Relative To Peers?"
2020-01-13,Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance
2020-01-03,Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2019-12-13,Hedge Funds Are Dumping Calithera Biosciences Inc (CALA)
2019-12-06,Data from Investigator-Sponsored Phase 2 Study of Calitheras Telaglenastat with Azacitidine in Myelodysplastic Syndrome to be Presented at ASH Annual Meeting 2019
2019-12-05,Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-12-04,Edited Transcript of CALA earnings conference call or presentation 12-Nov-19 10:00pm GMT
2019-12-02,Imagine Owning Calithera Biosciences (NASDAQ:CALA) While The Price Tanked 64%
2019-11-12,Calithera Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights
2019-11-05,Calithera to Present Preclinical Data from IL4I1 and CD73 Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
2019-11-04,"Calithera Biosciences to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019"
2019-10-19,"Read This Before Selling Calithera Biosciences, Inc. (NASDAQ:CALA) Shares"
2019-10-18,These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year
2019-10-07,Calithera (CALA) Completes Enrollment in Mid-Stage RCC Study
2019-10-03,Calithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma
2019-10-01,Calithera Announces Acceptance of Two Abstracts for Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
2019-09-29,New Data Presented at ESMO Congress 2019 from the Arginase Inhibitor INCB001158 Alone and in Combination with Pembrolizumab
2019-09-28,Data From Randomized Phase 2 ENTRATA Study Demonstrate Telaglenastat with Everolimus Improves Progression-Free Survival in Renal Cell Carcinoma
2019-09-27,Calithera Biosciences Enters Oversold Territory
2019-09-26,Calithera to Host Webcast Conference Call for Analysts and Investors During European Society for Medical Oncology (ESMO) Congress 2019
2019-09-26,Implied Volatility Surging for Calithera (CALA) Stock Options
2019-09-25,Calithera to Present at the 2019 Cantor Global Healthcare Conference
2019-09-19,"Calithera Biosciences, Inc. (NASDAQ:CALA): Is It Growing Too Fast?"
2019-09-09,Edited Transcript of CALA earnings conference call or presentation 8-Aug-19 9:00pm GMT
2019-08-28,Calithera to Participate in Wells Fargo Healthcare Conference and Citi 14th Annual Biotech Conference
2019-08-23,"Is Calithera Biosciences, Inc.'s (NASDAQ:CALA) CEO Pay Justified?"
2019-08-08,Calithera Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights
2019-08-01,"Calithera Biosciences to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019"
2019-07-24,"Does Calithera Biosciences, Inc. (NASDAQ:CALA) Have A High Beta?"
2019-07-02,Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with Pfizers CDK4/6 Inhibitor Palbociclib
2019-06-27,"Calithera Biosciences Inc (CALA) PRESIDENT AND CEO Susan Molineaux Bought $200,208 of Shares"
2019-06-21,"Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares"
2019-06-18,"Calithera Biosciences, Inc. Prices Public Offering of 12,500,000 shares of Common Stock"
2019-06-18,Did You Miss Calithera Biosciences's (NASDAQ:CALA) 37% Share Price Gain?
2019-06-17,"Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock"
2019-06-17,"Health Care Digest: Not-so-secret target of new UC-GSK alliance, East Bay toolmaker's big round and more"
2019-06-17,Calithera's Kidney Cancer Drug Doubles Progression-Free Survival Vs. Chemotherapy
2019-06-17,Calithera Achieves Positive Topline Results in Randomized Phase 2 ENTRATA Study of Telaglenastat with Everolimus in Renal Cell Carcinoma
2019-05-23,Edited Transcript of CALA earnings conference call or presentation 9-May-19 9:00pm GMT
